KMDA Q1 2025 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$520M

Q1 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$44M+16.6% YoY

Gross Profit

$21M47.1% margin

Operating Income

$8M17.7% margin

Net Income

$4M9.0% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+12.9%

Cash Flow

Operating Cash Flow

-$513,000

Free Cash Flow

-$2M

Stock-Based Comp.

$175,000

Balance Sheet

Total Assets

$375M

Total Liabilities

$123M

Stockholders' Equity

$252M

Cash & Equivalents

$76M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$38M	+16.6%
Gross Profit	$21M	$17M	+23.9%
Operating Income	$8M	$4M	+93.0%
Net Income	$4M	$2M	+67.6%